CLINICAL_TRIALS
research
· 2026-03-19
Clinical Trial Update: ASCT With TEAM Conditioning for Lymphoma With High Risk of CNS Relapse [Phase 2]
Summary
A Phase 2 clinical trial evaluating autologous stem cell transplantation with TEAM conditioning for lymphoma patients at high risk of central nervous system rel…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Lymphoma Patients With High-risk of Central Nervous System Relapse | Phase 2 | Status: RECRUITING